Posted inBiotechnology
Virion Movement in Sialoglycan-Cleaving Respiratory Viruses
In the ongoing battle against respiratory pathogens, a groundbreaking study has illuminated a previously underappreciated aspect of viral behavior: the…
Posted inBiotechnology
Ingestible Capsules Enable Microbe-Based Therapeutic Control
In an extraordinary leap at the crossroads of synthetic biology and digital health technology, researchers have unveiled a pioneering system…
Posted inGenetics
Antimicrobial Resistance Strategies May Be Informed by Bacteria’s Kiwa Phage Defense System
Researchers at the University of Southampton have used advanced imaging techniques to uncover how bacteria use a mechanism called Kiwa…
Posted inBiotechnology
Bariatric Surgery’s Impact on Circulating S100A9
Bariatric surgery (BS) has long been celebrated for its transformative impact on individuals grappling with obesity, not merely by promoting…
Posted inGenetics
First Arab Human Pangenome Sequenced
Scientists published the first Arab human pangenome in Nature Communications, which was largely accomplished by using PacBio’s HiFi long-read sequencing.…
Posted inBiotechnology
Engineering Receptors to Enhance Flagellin Detection
In the ever-evolving battlefield of plant-pathogen interactions, the intricate dance between plant immune receptors and microbial invaders continues to captivate…
Posted inBiotechnology
Hydrogels in Food: Advances, Challenges, and Insights
In recent years, the intersection of food technology and materials science has witnessed a groundbreaking advancement with the emergence of…
Posted inBiotechnology
Agomelatine Restores Mitochondria, Rescues Oocyte Meiosis
In recent years, the intersection of obesity and female fertility has emerged as a critical area of biomedical research, unveiling…
Posted inBiotechnology
Arrowhead says beleaguered Sarepta has 60 days to pay $100M in milestone
After assuring investors last week that beleaguered Sarepta Therapeutics would likely fulfill its financial duties in a deal with Arrowhead…
Posted inBiotechnology
Radiopharma-focused Artbio paints path to clinic with $132M series B
Radiopharmaceuticals-focused Artbio has drawn in a $132 million series B to push its lead prostate cancer prospect through phase 2…